Global Dialysis Market

Global Dialysis Market Size, Share, Growth Analysis, By Type(Products, Services), By Dialysis Type(Hemodialysis, Peritoneal Dialysis), By End-User(Dialysis Centers & Hospitals, Home Care) - Industry Forecast 2024-2031


Report ID: SQSG35A2061 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 87 | Figures: 76

Global Dialysis Market Dynamics

Dialysis Market Driver

  • In terms of cost and healthcare services, the overall burden of end-stage renal disease (ESRD) and chronic kidney disease (CKD) is one of the highest. One of the primary drivers of market expansion is the increasing prevalence of chronic kidney disease and renal failure. ESRD occurs when one or both kidneys cease to function correctly and the patient requires long-term renal infusion therapy or a kidney transplant. Thus, the rising frequency of ESRD is increasing the global financial burden of kidney disorders and is one of the primary drivers driving the increased revenue generation from services. According to the CDC, around 15% of the US population and 14% of Hispanics have CKD.
  • The frequency of CKD has risen dramatically, fueling demand for efficient renal services with shorter wait times. The growing availability of highly qualified nephrologists in affluent countries has boosted the number of renal care institutions. Furthermore, to meet the increased need for renal care in emerging economies, investors are concentrating their efforts on expanding renal treatment centers in nations such as India, China, and Mexico. This is projected to propel market revenue generation in the following years. The availability of low-cost care in these countries is increasing the frequency of visitors to these clinics.

Dialysis Market Restraint

  • Kidney transplantation is one of the alternative therapy choices for people with ESRD and stage III CKD, in which the patients receive a kidney from a donor and a healthy kidney replaces the damaged kidney. Better treatment outcomes associated with kidney transplant and the affordability of the surgery as a result of favorable reimbursement policies are expected to influence market growth over the forecast period. Patients with ESRD prefer kidney transplantation versus renal infusion because to the long-term benefits of the treatment. In addition, published studies and journals have indicated a rise in the cost of renal therapy as a result of the coronavirus epidemic in India. This could have a detrimental impact on market growth.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Dialysis Market size was valued at USD 108.7 billion in 2019 and is poised to grow from USD 122.47 billion in 2023 to USD 196.1 billion by 2031, growing at a CAGR of 6.78% in the forecast period (2024-2031).

The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions. 'Fresenius Medical Care AG & Co. KGaA', 'Baxter International Inc.', 'DaVita Inc.', 'Nipro Corporation', 'B. Braun Melsungen AG', 'Diaverum Deutschland GmbH', 'Asahi Kasei Corporation', 'Nikkiso Co. Ltd.', 'NxStage Medical, Inc.', 'Toray Industries, Inc.', 'Medtronic plc', 'Rockwell Medical Technologies, Inc.', 'JMS Co., Ltd.', 'Satellite Healthcare, Inc.', 'AllMed Medical GmbH', 'Fresenius Kabi AG', 'Quanta Dialysis Technologies Ltd.', 'Outset Medical, Inc.', 'Medivators Inc.', 'Gambro AB (acquired by Baxter International Inc.)'

In terms of cost and healthcare services, the overall burden of end-stage renal disease (ESRD) and chronic kidney disease (CKD) is one of the highest. One of the primary drivers of market expansion is the increasing prevalence of chronic kidney disease and renal failure. ESRD occurs when one or both kidneys cease to function correctly and the patient requires long-term renal infusion therapy or a kidney transplant. Thus, the rising frequency of ESRD is increasing the global financial burden of kidney disorders and is one of the primary drivers driving the increased revenue generation from services. According to the CDC, around 15% of the US population and 14% of Hispanics have CKD.

Renal dialysis market trend has been identified as the shift of patients from clinics to homecare settings. Patients with end-stage renal disease (ESRD) must receive care at a renal facility or might choose to receive these treatments at home. One of the market's significant trends is the growing desire of patients for receiving care at home, particularly in developed economies. Furthermore, governments in countries such as the United States are working to establish new payment ways for treating renal illness, which may favor lower-cost care at home. This is expected to increase the number of patients seeking treatment in home care settings in the future years.

In 2021, North America is expected to have the biggest share of the market during the forecast period. The high prevalence of CKD and ESRD in the United States and Canada, together with greater treatment rates in these countries, are expected to drive market growth over the projected period. The increased incidence of coronavirus infections and resultant renal failures is also expected to increase demand for services and products in the United States.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Dialysis Market

Product ID: SQSG35A2061

$5,300
BUY NOW GET FREE SAMPLE